Mechanism of activation of AMPK and upregulation of OGG1 by rapamycin in cancer cells

Oncotarget

Volumn 2, Issue 12, 2011, Pages 958-959

  Habib, Samy L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DNA GLYCOSYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MTOR PROTEIN, HUMAN; OXOGUANINE GLYCOSYLASE 1, HUMAN; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

EDITORIAL; HUMAN; METABOLISM; NEOPLASM;

AMP-ACTIVATED PROTEIN KINASES; ANTIBIOTICS, ANTINEOPLASTIC; DNA GLYCOSYLASES; HUMANS; NEOPLASMS; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84862995649     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.381     Document Type: Editorial

References (8)

1. Hardie, D.G. J Cell Sci, 2004, 117: 5479-87.
2. Guo D, Hildebrandt IJ, Prins RM, et al. Proc Natl Acad Sci U S A., 2009,106: 12932-7.
3. Dancey J. Nat Rev Clin Oncol, 2010, 7: 209-219.
4. Sarbassov, D.D. et al. Science, 2005, 307: 1098-1101.
5. Bissler JJ, McCormack FX, Young LR, et al. N Engl J Med., 2008, 358: 140-151.
6. Dan HC, Sun M, Yang L, et al. J Biol Chem 2002, 277: 35364-35370.
7. Audebert, M, Chevillard S, C. Levalois, et al. Cancer Res, 2000, 60: 4740-4744.
8. Habib SL, Kasinath BS, Arya RR, et al. Eur J Cancer, 2010, 46: 2806-20.